These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27638602)

  • 1. Cellular transplant therapies for globoid cell leukodystrophy: Preclinical and clinical observations.
    Maher KR; Yeager AM
    J Neurosci Res; 2016 Nov; 94(11):1180-8. PubMed ID: 27638602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin repair by transplantation of myelin-forming cells in globoid cell leukodystrophy.
    Kondo Y; Duncan ID
    J Neurosci Res; 2016 Nov; 94(11):1195-202. PubMed ID: 27557886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Trafficking and Processing of GALC Mutants Correlates with Globoid Cell Leukodystrophy Severity.
    Shin D; Feltri ML; Wrabetz L
    J Neurosci; 2016 Feb; 36(6):1858-70. PubMed ID: 26865610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for Krabbe's disease: Finding the combination.
    Mikulka CR; Sands MS
    J Neurosci Res; 2016 Nov; 94(11):1126-37. PubMed ID: 27638598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical, electrophysiological, and biochemical markers of peripheral and central nervous system disease in canine globoid cell leukodystrophy (Krabbe's disease).
    Bradbury AM; Bagel JH; Jiang X; Swain GP; Prociuk ML; Fitzgerald CA; O'Donnell PA; Braund KG; Ory DS; Vite CH
    J Neurosci Res; 2016 Nov; 94(11):1007-17. PubMed ID: 27638585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model.
    Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL
    Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of AAV/GALC vectors in 10-11-day-old twitcher mice improves survival and is enhanced by bone marrow transplant.
    Karumuthil-Melethil S; Marshall MS; Heindel C; Jakubauskas B; Bongarzone ER; Gray SJ
    J Neurosci Res; 2016 Nov; 94(11):1138-51. PubMed ID: 27638599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy of a novel humanized mouse model of globoid cell leukodystrophy.
    Matthes F; Andersson C; Stein A; Eistrup C; Fogh J; Gieselmann V; Wenger DA; Matzner U
    Exp Neurol; 2015 Sep; 271():36-45. PubMed ID: 25956830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigation of cerebellar neuropathy in globoid cell leukodystrophy mice by AAV-mediated gene therapy.
    Lin DS; Hsiao CD; Lee AY; Ho CS; Liu HL; Wang TJ; Jian YR; Hsu JC; Huang ZD; Lee TH; Chiang MF
    Gene; 2015 Oct; 571(1):81-90. PubMed ID: 26115766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy.
    Hawkins-Salsbury JA; Shea L; Jiang X; Hunter DA; Guzman AM; Reddy AS; Qin EY; Li Y; Gray SJ; Ory DS; Sands MS
    J Neurosci; 2015 Apr; 35(16):6495-505. PubMed ID: 25904800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of mouse embryonic stem cell-derived oligodendrocytes in the murine model of globoid cell leukodystrophy.
    Kuai XL; Ni RZ; Zhou GX; Mao ZB; Zhang JF; Yi N; Liu ZX; Shao N; Ni WK; Wang ZW
    Stem Cell Res Ther; 2015 Mar; 6(1):30. PubMed ID: 25888852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective on innovative therapies for globoid cell leukodystrophy.
    Ricca A; Gritti A
    J Neurosci Res; 2016 Nov; 94(11):1304-17. PubMed ID: 27638612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
    Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
    J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multipotent stromal cells alleviate inflammation, neuropathology, and symptoms associated with globoid cell leukodystrophy in the twitcher mouse.
    Scruggs BA; Zhang X; Bowles AC; Gold PA; Semon JA; Fisher-Perkins JM; Zhang S; Bonvillain RW; Myers L; Li SC; Kalueff AV; Bunnell BA
    Stem Cells; 2013 Aug; 31(8):1523-34. PubMed ID: 23606584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-based high-throughput screening identifies galactocerebrosidase enhancers as potential small-molecule therapies for Krabbe's disease.
    Jang DS; Ye W; Guimei T; Solomon M; Southall N; Hu X; Marugan J; Ferrer M; Maegawa GH
    J Neurosci Res; 2016 Nov; 94(11):1231-45. PubMed ID: 27638606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Globoid cell leukodystrophy (Krabbe's disease): update.
    Suzuki K
    J Child Neurol; 2003 Sep; 18(9):595-603. PubMed ID: 14572137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2.
    Lin D; Fantz CR; Levy B; Rafi MA; Vogler C; Wenger DA; Sands MS
    Mol Ther; 2005 Sep; 12(3):422-30. PubMed ID: 15996520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of galactosylceramidase (GALC) expression in the twitcher mouse model of globoid cell leukodystrophy (GLD) is caused by nonsense-mediated mRNA decay (NMD).
    Lee WC; Tsoi YK; Dickey CA; Delucia MW; Dickson DW; Eckman CB
    Neurobiol Dis; 2006 Aug; 23(2):273-80. PubMed ID: 16759875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GALC transduction leads to morphological improvement of the twitcher oligodendrocytes in vivo.
    Meng XL; Shen JS; Watabe K; Ohashi T; Eto Y
    Mol Genet Metab; 2005 Apr; 84(4):332-43. PubMed ID: 15781194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human iPSC-based neurodevelopmental models of globoid cell leukodystrophy uncover patient- and cell type-specific disease phenotypes.
    Mangiameli E; Cecchele A; Morena F; Sanvito F; Matafora V; Cattaneo A; Della Volpe L; Gnani D; Paulis M; Susani L; Martino S; Di Micco R; Bachi A; Gritti A
    Stem Cell Reports; 2021 Jun; 16(6):1478-1495. PubMed ID: 33989519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.